Kurt Schalper
Nanoscience and Nanotechnology
 Viralytics
Australia
Biography
Dr Schalper is focused on leveraging advances in targeted therapy and immunotherapy to develop new treatments that will improve outcomes for cancer patients. He is a member of a Stand Up To Cancer – American Cancer Society Dream Team formed to discover novel, targeted immunological approaches to treating KRAS-mutant lung cancers. At Yale, he also helped to develop a new objective, quantitative, and reproducible assay for measuring anti-tumour immune activity in non-small cell lung cancer tumours – an advance that could lead to novel immunostimulatory therapies.
Research Interest
Nanoscience and Nanotechnology
